SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmacyclics (PCYC) -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (452)5/20/1999 10:17:00 AM
From: ouija  Respond to of 717
 
well, maybe that is where the rule-of-4 I am talking about comes from...nobody can copy DUSA's work even after the patents run out without a total of 4 entities first going through all the trials with their specific drug-device combination. It creates a great barrier to entry. Almost makes me want to focus on drug-device companies exclusively.



To: Biomaven who wrote (452)6/11/1999 12:09:00 PM
From: LLCF  Read Replies (1) | Respond to of 717
 
Jeez.... whats up over here in PCYC??? I see no news... virtually no option volume... strange.

DAK